" class="no-js "lang="en-US"> Immunology Archives - Page 2 of 11 - Medtech Alert
Thursday, October 02, 2025

Sort by:

Date

Top Post

SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer Detection Test

SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE […]

Compugen Announces Appointment of Alberto Sessa as Chief Financial Officer

Compugen Ltd. ( Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced […]

NeoImmuneTech's NT-I7 Creates a More Immunogenic Tumor Microenvironment when Associated with Pembrolizumab

NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, presented data that suggests that NT-I7 plus […]

Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to […]

Verseon Gains European Patent Protection for Potential Sight and Life-Saving Treatments

Verseon is pleased to announce that the European Patent Office has granted intellectual property protection […]

Elephas Announces $41.5 Million in Series B Funding

Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $41.5 million in Series […]

Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU

Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer […]

Lytix Biopharma Appoints Stephen Worsley as Chief Business Officer

Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment […]

Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator

Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy […]

IVX Health Announces Opening of New Infusion Centers in Connecticut

IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more